Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Prostate Cancer, nmCRPC

Eric Small

MD

🏢University of California, San Francisco🌐USA

Professor of Medicine and Urology; Deputy Director, UCSF Helen Diller Family Comprehensive Cancer Center

71
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Eric Small is a preeminent prostate cancer clinical investigator at UCSF who co-led the PROSPER trial establishing enzalutamide for nmCRPC. He has been central to developing novel hormonal therapies for castration-resistant prostate cancer across the disease spectrum. His laboratory and clinical work investigates androgen receptor biology and mechanisms of treatment resistance. Small has held leadership roles in major cooperative oncology groups and has shaped the landscape of prostate cancer therapeutics.

Share:

🧪Research Fields 研究领域

nmCRPC trials
PROSPER trial
enzalutamide
androgen receptor
prostate cancer clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Eric Small 的研究动态

Follow Eric Small's research updates

留下邮箱,当我们发布与 Eric Small(University of California, San Francisco)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment